Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:1155

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2006;113:1155.)
© 2006 American Heart Association, Inc.

Issue Highlights


*    PREVENTION OF SYNCOPE TRIAL (POST): A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF METOPROLOL IN THE PREVENTION OF VASOVAGAL SYNCOPE, Sheldon et al.
up arrowTop
*PREVENTION OF SYNCOPE TRIAL...
down arrowDRIVING TIMES AND DISTANCES...
down arrowFACTOR XIII DEFICIENCY CAUSES...
down arrowClinician Update
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence.
 
Stimulation of cardiac mechanoreceptors by vigorous cardiac contraction has been implicated in eliciting the reflex sympathetic withdrawal and parasympathetic activation that causes neurocardiogenic (vasovagal syncope). ß-Adrenergic blockers are commonly prescribed, and failure to consistently confirm benefit in controlled trials has been attributed to inclusion of patients with uncharacterized causes of syncope and a spectrum of ages. Sheldon and coworkers conducted a randomized controlled trial of metoprolol in patients with recurrent vasovagal syncope that could be confirmed on tilt table testing. Metoprolol failed to provide benefit. Additional analysis of age and the requirement for isoproterenol infusion to provoke a positive tilt table test are presented. The failure of ß-blocker therapy raises further questions as to the mechanisms eliciting vasovagal syncope and has important implications for treatment. See p 1164.


*    DRIVING TIMES AND DISTANCES TO HOSPITALS WITH PERCUTANEOUS CORONARY INTERVENTION IN THE UNITED STATES: IMPLICATIONS FOR PREHOSPITAL TRIAGE OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION, Nallamothu et al.
up arrowTop
up arrowPREVENTION OF SYNCOPE TRIAL...
*DRIVING TIMES AND DISTANCES...
down arrowFACTOR XIII DEFICIENCY CAUSES...
down arrowClinician Update
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence.
 
There is growing interest in regionalization of care for patients with ST-elevation myocardial infarction (STEMI) and the prehospital ambulance triage of these patients to PCI hospitals. However, delays that are incurred from directly transporting patients to a PCI hospital may eliminate the advantage of primary PCI or even place the patient at a disadvantage if a closer, non-PCI hospital is available but bypassed. The success of prehospital triage protocols depend in large part on how patients are geographically distributed around hospitals with and without percutaneous coronary intervention and other advanced technologies. To address this issue, investigators from the University of Michigan and Yale University estimated driving times and distances to the nearest PCI hospital for the adult population in the United States. Furthermore, they estimated the additional driving time and distance required to reach the nearest PCI hospital when a closer non-PCI hospital was available. These latter findings, in particular, have important implications for the design of prehospital triage protocols across the United States. See p 1189.


*    FACTOR XIII DEFICIENCY CAUSES CARDIAC RUPTURE, IMPAIRS WOUND HEALING, AND AGGRAVATES CARDIAC REMODELING IN MICE WITH MYOCARDIAL INFARCTION, Nahrendorf et al.
up arrowTop
up arrowPREVENTION OF SYNCOPE TRIAL...
up arrowDRIVING TIMES AND DISTANCES...
*FACTOR XIII DEFICIENCY CAUSES...
down arrowClinician Update
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence.
 
Factor XIII (FXIII) is a circulating clotting factor that has also been shown to play a role in wound healing. In this study, Nahrendorf and colleagues examined mice deficient in FXIII to determine if this clotting factor also contributes to left ventricular remodeling and healing after myocardial infarction. Mice deficient in FXIII died from cardiac rupture but morbidity was prevented by intravenous FXIII supplementation. The conclusion of the study is that FXIII is important for remodeling of the myocardium after infarction. Although preliminary, these studies suggest a potential target to facilitate myocardial healing after ischemia and injury. See p 1196.

Visit http://circ.ahajournals.org:


*    Clinician Update
up arrowTop
up arrowPREVENTION OF SYNCOPE TRIAL...
up arrowDRIVING TIMES AND DISTANCES...
up arrowFACTOR XIII DEFICIENCY CAUSES...
*Clinician Update
down arrowImages in Cardiovascular...
down arrowBook Review
down arrowCorrespondence.
 
Inflammatory Biomarkers in Acute Coronary Syndromes: Part IV: Matrix Metalloproteinases and Biomarkers of Platelet Activation. See p e382.


*    Images in Cardiovascular Medicine
up arrowTop
up arrowPREVENTION OF SYNCOPE TRIAL...
up arrowDRIVING TIMES AND DISTANCES...
up arrowFACTOR XIII DEFICIENCY CAUSES...
up arrowClinician Update
*Images in Cardiovascular...
down arrowBook Review
down arrowCorrespondence.
 
Diagnosis of a "Single" Coronary Artery and Determination of Functional Significance of Concomitant Coronary Artery Disease. See p e386.

Left Ventricle Apical Conduit to Bilateral Subclavian Artery in a Patient With Porcelain Aorta and Aortic Stenosis. See p e388.

Myocardial Bridging. See p e390. Down


Figure 1
View larger version (107K):
[in this window]
[in a new window]
 


*    Book Review
up arrowTop
up arrowPREVENTION OF SYNCOPE TRIAL...
up arrowDRIVING TIMES AND DISTANCES...
up arrowFACTOR XIII DEFICIENCY CAUSES...
up arrowClinician Update
up arrowImages in Cardiovascular...
*Book Review
down arrowCorrespondence.
 
Pulmonary Circulation: Diseases and Their Treatment. See p e392.


*    Correspondence.
up arrowTop
up arrowPREVENTION OF SYNCOPE TRIAL...
up arrowDRIVING TIMES AND DISTANCES...
up arrowFACTOR XIII DEFICIENCY CAUSES...
up arrowClinician Update
up arrowImages in Cardiovascular...
up arrowBook Review
*Correspondence.
 
See p e393.


Related Articles:

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States: Implications for Prehospital Triage of Patients With ST-Elevation Myocardial Infarction
Brahmajee K. Nallamothu, Eric R. Bates, Yongfei Wang, Elizabeth H. Bradley, and Harlan M. Krumholz
Circulation 2006 113: 1189-1195. [Abstract] [Full Text]

Inflammatory Biomarkers in Acute Coronary Syndromes: Part IV: Matrix Metalloproteinases and Biomarkers of Platelet Activation
Ehrin J. Armstrong, David A. Morrow, and Marc S. Sabatine
Circulation 2006 113: e382-e385. [Extract] [Full Text]

Diagnosis of a "Single" Coronary Artery and Determination of Functional Significance of Concomitant Coronary Artery Disease
C. Jahnke, E. Nagel, P.C. Ostendorf, T. Tangcharoen, E. Fleck, and I. Paetsch
Circulation 2006 113: e386-e387. [Extract] [Full Text]

Left Ventricle Apical Conduit to Bilateral Subclavian Artery in a Patient With Porcelain Aorta and Aortic Stenosis
Kuan-Ming Chiu, Tzu-Yu Lin, Jer-Shen Chen, Shao-Jung Li, Chih-Yang Chan, and Shu-Hsun Chu
Circulation 2006 113: e388-e389. [Extract] [Full Text]

Myocardial Bridging
Sebastiaan C.A.M. Bekkers and Tim Leiner
Circulation 2006 113: e390-e391. [Extract] [Full Text]

Pulmonary Circulation: Diseases and Their Treatment
Harrison W. Farber
Circulation 2006 113: e392. [Extract] [Full Text]

Letter Regarding Article by Weitzman et al, "Tobacco Smoke Exposure Is Associated With the Metabolic Syndrome in Adolescents"
Celia M. Ross, Michael Weitzman, Stephen Cook, Peggy Auinger, Todd Florin, Stephen Daniels, Michael Nguyen, and Jonathan Winickoff
Circulation 2006 113: e393. [Extract] [Full Text]

Prevention of Syncope Trial (POST): A Randomized, Placebo-Controlled Study of Metoprolol in the Prevention of Vasovagal Syncope
Robert Sheldon, Stuart Connolly, Sarah Rose, Thomas Klingenheben, Andrew Krahn, Carlos Morillo, Mario Talajic, Teresa Ku, Fetnat Fouad-Tarazi, Debbie Ritchie, Mary-Lou Koshman for the POST Investigators
Circulation 2006 113: 1164-1170. [Abstract] [Full Text]

Factor XIII Deficiency Causes Cardiac Rupture, Impairs Wound Healing, and Aggravates Cardiac Remodeling in Mice With Myocardial Infarction
Matthias Nahrendorf, Kai Hu, Stefan Frantz, Farouc A. Jaffer, Ching-Hsuan Tung, Karl-Heinz Hiller, Sabine Voll, Peter Nordbeck, David Sosnovik, Stefan Gattenlöhner, Mikhail Novikov, Gerhard Dickneite, Guy L. Reed, Peter Jakob, Anthony Rosenzweig, Wolfgang R. Bauer, Ralph Weissleder, and Georg Ertl
Circulation 2006 113: 1196-1202. [Abstract] [Full Text]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles